Browse
Submit Data
Databases
API
Help

Dataset Information

20 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

{2-[(4-Bromo-phen-yl)imino-meth-yl]pyridine-κN,N'}diiodidozinc(II).

ABSTRACT: In the title compound, [ZnI(2)(C(12)H(9)BrN(2))], the metal centre displays a moderately distorted tetra-hedral coordination geometry defined by two iodide anions and two N atoms of the organic ligand. The dihedral angle between the pyridine and benzene rings is 15.15 (13)°.

SUBMITTER: Khalaj M

PROVIDER: S-EPMC2961941 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Similar Datasets

{2,6-Bis[(4-bromo-phen-yl)imino-meth-yl]pyridine-κN,N',N''}trichlorido-chromium(III).

Project description:In the title compound, [CrCl(3)(C(19)H(13)Br(2)N(3))], the Cr(3+ )ion is coordinated by the tridentate 2,6-bis-[(4-bromo-phen-yl)imino-meth-yl]pyridine Schiff base ligand in a fac-octa-hedral geometry. The dihedral angles between the pyridine and benzene rings are 23.9 (6) and 70.7 (1)°.

| S-EPMC2983151 | biostudies-literature

Dibromido{2-[(4-nitro-phen-yl)imino-meth-yl]pyridine-κN,N'}zinc(II).

Project description:In the title compound, [ZnBr(2)(C(12)H(9)N(3)O(2))], the Zn(II) ion is bonded to two Br ions and two N atoms of the diimine ligand in a distorted tetra-hedral geometry. With the exception of the Br atoms, all other atoms are disordered over two sets of sites corresponding to a 180° rotation of the mol-ecule along [[Formula: see text]02]. The refined occupancies of the components are 0.809 (2) and 0.191 (2). In addition, the crystal studied was a non-merohedral twin with a refined component ratio of 0.343 (2):0.657 (2).

| S-EPMC3246977 | biostudies-literature

Dichlorido{2-[(4-iodo-phen-yl)imino-meth-yl]pyridine-κN,N'}copper(II).

Project description:The Cu(II) atom in the title complex, [CuCl(2)(C(12)H(9)IN(2))], has a square-planar coordination being N,N'-chelated by the Schiff base ligand, and by two Cl atoms. The geometry is distorted towards square pyramidal owing to a long Cu⋯Cl inter-action of 2.941 (1) Å. This results in the formation of a zigzag chain structure propagating in the c-axis direction.

| S-EPMC2977602 | biostudies-literature

Dichlorido{2-[(3,4-dimethyl-phen-yl)imino-meth-yl]pyridine-κN,N'}copper(II).

Project description:In the title complex, [CuCl(2)(C(14)H(14)N(2))], the Cu(II) atom exhibits a very distorted tetra-hedral coordination geometry involving two chloride ions and two N-atom donors from the Schiff base ligand. The range for the six bond angles about the Cu(2+) cation is 81.49 (11)-145.95 (9)°. The chelate ring including the Cu(II) atom is approximately planar, with a maximum deviation of 0.039 (4) Å for one of the C atoms; this plane forms a dihedral angle of 46.69 (9)° with the CuCl(2) plane.

| S-EPMC3247544 | biostudies-literature

Dibromido{2-[(4-bromo-phen-yl)imino-meth-yl]pyridine-?N,N'}zinc(II).

Project description:In the title complex, [ZnBr(2)(C(12)H(9)BrN(2))], the Zn(II) ion is in a distorted tetra-hedral coordination environment formed by two imine N atoms of the bis-chelating N-heterocyclic ligand and two Br atoms. The dihedral angle between the pyridine and benzene rings is 8.04?(17)°.

| S-EPMC2977329 | biostudies-literature

Bis{2-[(4-bromo-phen-yl)imino-meth-yl]pyridine-κN,N'}copper(I) tetra-phenyl-borate.

Project description:In the crystal structure of the title compound, [Cu(C(12)H(9)BrN(2))(2)](C(24)H(20)B), the copper(I) cation is coordinated by four N atoms of two crystallographically independent 2-[(4-bromo-phen-yl)imino-meth-yl]pyridine ligands within a distorted tetra-hedron.

| S-EPMC2961942 | biostudies-literature

{2-[(2,5-Dimethyl-phen-yl)imino-methyl]pyridine-?N,N'}diiodidozinc(II).

Project description:In the mol-ecule of the title compound, [ZnI(2)(C(14)H(14)N(2))], the Zn atom is four-coordinated in a distorted tetra-hedral geometry by two N atoms of the Schiff base ligand and by two I atoms. The benzene and pyridine rings are oriented at a dihedral angle of 70.75?(3)°. The five-membered ring has an envelope conformation. There is a weak ?-? inter-action between benzene rings, with a centroid-to-centroid distance of 3.975?(4)?Å.

| S-EPMC2960630 | biostudies-literature

Di-?-chlorido-bis-({2-[(4-bromo-phen-yl)-imino-meth-yl]pyridine-?N,N'}-chloridomercury(II)).

Project description:The unique Hg(II) ion in the title centrosymmetric dinuclear complex, [Hg(2)Cl(4)(C(12)H(9)BrN(2))(2)], is in a distorted trigonal-bipyramidal coordination environment formed by the bis-chelating N-heterocyclic ligand, two bridging Cl atoms and one terminal Cl atom. One of the bridging Hg-Cl bonds is significantly longer than the other.

| S-EPMC2977257 | biostudies-literature

Di-μ-chlorido-bis-(chlorido{2-[(4-ethyl-phen-yl)imino-meth-yl]pyridine-κN,N'}copper(II)).

Project description:The binuclear title complex, [Cu(2)Cl(4)(C(14)H(14)N(2))(2)], is located on a crystallographic inversion centre. The Cu(II) ion is in a distorted square-pyramid coordination environment formed by the bichelating N-heterocyclic ligand, two bridging Cl atoms and one terminal Cl atom. One of the bridging Cu-Cl bonds is significantly longer than the other.

| S-EPMC3200970 | biostudies-literature

{4-Bromo-2-[3-(diethyl-ammonio)propyl-imino-meth-yl]phenolato}diiodidozinc(II) methanol solvate.

Project description:In the title complex, [ZnI(2)(C(14)H(21)BrN(2)O)]·CH(3)OH, the asymmetric unit consists of a mononuclear zinc(II) complex mol-ecule and a methanol solvent mol-ecule. The compound was derived from the zwitterionic form of the Schiff base 4-bromo-2-[3-(diethyl-amino)propyl-imino-meth-yl]phenol. The Zn(II) atom is four-coordinated by the imine N and phenolate O atoms of the Schiff base ligand and by two iodide ions in a distorted tetra-hedral coordination. In the crystal structure, the methanol mol-ecules are linked to the Schiff base mol-ecules through N-H?O and O-H?O hydrogen bonds. One I atom is disordered over two positions in a 0.702?(19):0.298?(19) ratio.

| S-EPMC2971364 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data